Synergistic Monitoring System for Drug-Impaired Subjects

Publication ID: 24-11857334_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Monitoring System for Drug-Impaired Subjects,” Published Technical Disclosure No. 24-11857334_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857334_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,334.

Summary of the Inventive Concept

A novel system integrating EEG, IoT, blockchain, and AI technologies to monitor and analyze physiological signals of subjects under the influence of drugs, providing a more accurate and secure drug profile.

Background and Problem Solved

The original patent addressed the critical issue of monitoring subjects under the influence of drugs, but it had limitations in terms of data security, decentralized storage, and advanced analytics. The new inventive concept overcomes these limitations by synergistically combining distinct technologies to create a more powerful system.

Detailed Description of the Inventive Concept

The Synergistic Monitoring System comprises a wearable IoT device collecting physiological signals, a blockchain-based data storage module ensuring secure data transmission, and a machine learning module utilizing AI algorithms to analyze the signals and predict a drug profile. The system can be integrated with various sensors, including EEG, EMG, oxygenation, and heart rate sensors, to provide a comprehensive picture of the subject's physiological state. The AI-powered analytics enable the identification of patterns in physiological signals, generating a personalized drug profile for each subject.

Novelty and Inventive Step

The new claims introduce the innovative combination of EEG, IoT, blockchain, and AI technologies, which provides a more accurate, secure, and decentralized system for monitoring subjects under the influence of drugs. The inventive step lies in the synergistic integration of these distinct technologies, enabling a more comprehensive and personalized approach to drug profiling.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different types of sensors, such as implantable or ingestible sensors, or the integration of additional AI algorithms for more advanced analytics. Variations may also include the development of specialized systems for specific types of drugs or patient populations.

Potential Commercial Applications and Market

The Synergistic Monitoring System has significant commercial potential in the healthcare and pharmaceutical industries, particularly in the areas of drug abuse treatment, clinical research, and personalized medicine. The system's ability to provide accurate and secure drug profiling can improve patient outcomes, reduce healthcare costs, and enhance the development of new treatments.

Original Patent Information

Patent NumberUS 11,857,334
TitleSystems and methods for monitoring a subject under the influence of drugs
Assignee(s)The General Hospital Corporation